Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

zerohedge.com - Tyler Durden - The Big Pharma Psychedelic Buyout Spree Has Begun
The Big Pharma Psychedelic Buyout Spree Has Begun
Zero Hedge

Massive validation for psychedelics…not as drugs, but as investments could be moments away. Just months after I argued for the millionth time that psychedelic drug developers were likely to become acquisition targets as the sector gained…

dawn.com - Ikram Junaidi - Investment pacts, not MoUs, to be signed at Pak-China pharma conference: minister
Investment pacts, not MoUs, to be signed at Pak-China pharma conference: minister
Dawn

ISLAMABAD: Health Minister Mustafa Kamal on Tuesday said a number of investment agreements, instead of memorandums of understanding (MoUs), will be signed during the Pak-China Pharmaceutical and Healthcare B2B Investment Conference, which begins on…

globenewswire.com - Arletta Pharma Solutions - Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US
Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US
GlobeNewswire

FDA endorses key elements of the proposed Phase 2 dose-ranging study and openness to a single pivotal Phase 3 study to support a future NDA Amsterdam, the Netherlands, 16 July 2026 — Arletta Pharma Solutions, a clinical-stage…

fool.com - Brendan Coffey - Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
The Motley Fool

Determining where to allocate capital in the healthcare sector often involves choosing between established stability and aggressive growth. Both Johnson & Johnson (JNJ +2.10%) and Eli Lilly and Co (LLY +1.31%) offer unique paths for investors.

thehindubusinessline.com - Explained: How the India-UK CETA could boost pharma, medtech exports
Explained: How the India-UK CETA could boost pharma, medtech exports
BusinessLine

The India-UK Comprehensive Economic and Trade Agreement (CETA) is expected to create a significant export opportunities for India's pharmaceutical, medical devices and healthcare sectors by providing duty-free access to the UK market and easing…

marketbeat.com - Citigroup Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
Citigroup Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target lifted by research analysts at Citigroup from $82.00 to $93.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a 'neutral' rating on the stock.

marketbeat.com - HC Wainwright Lowers Earnings Estimates for NervGen Pharma
HC Wainwright Lowers Earnings Estimates for NervGen Pharma
MarketBeat

NervGen Pharma (NASDAQ:NGEN - Free Report) - Investment analysts at HC Wainwright cut their Q2 2026 earnings per share estimates for NervGen Pharma in a research note issued on Tuesday, July 14th. HC Wainwright analyst R. Selvaraju now anticipates…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - What's Next?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - What's Next?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s stock price gapped up prior to trading on Thursday. The stock had previously closed at $19.24, but opened at $20.14. Ascentage Pharma Group International…

marketbeat.com - Athira Pharma, Inc. (NASDAQ:LONA) Receives Average Rating of 'Hold' from Analysts
Athira Pharma, Inc. (NASDAQ:LONA) Receives Average Rating of 'Hold' from Analysts
MarketBeat

Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) has earned an average rating of 'Hold' from the five research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Shares Purchased by Principal Financial Group Inc.
BridgeBio Pharma, Inc. $BBIO Shares Purchased by Principal Financial Group Inc.
MarketBeat

Principal Financial Group Inc. raised its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 1.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,330,415…

upi.com - Don Jacobson - FDA approves first pill to significantly lower 'bad' cholesterol
FDA approves first pill to significantly lower 'bad' cholesterol
UPI

July 16 (UPI) -- Heralding what some are calling a revolution in cholesterol management, U.S. regulators on Thursday approved the use of pill shown to significantly reduce dangerous 'LDL-C' cholesterol in at-risk adults. The Food and Drug…

thehindu.com - The Hindu Bureau - India-U.K. CETA to spur sourcing of textiles, food produce from Telangana, help attract more GCCs
India-U.K. CETA to spur sourcing of textiles, food produce from Telangana, help attract more GCCs
The Hindu

The India–UK Comprehensive Economic and Trade Agreement (CETA) that came into force on July 15 is expected to spur demand for textiles, agri produce, spices and marine products from the Telugu States, besides making several British firms…

forbes.com - Jennifer Waters - Why Customer Care Is More Of A Growth Engine Than A Cost Center
Why Customer Care Is More Of A Growth Engine Than A Cost Center
Forbes

Jennifer Waters, SVP at BioCareSD, is a leading voice in specialty pharma, championing transparency and industry innovation. ​The pop-up chatbot. The automated phone tree. The “your call is very important to us” recording…

thestandard.com.hk - The Standard 英文虎報 - Chinese drugmakers with big ambitions struggle to recruit staff for global expansion
Chinese drugmakers with big ambitions struggle to recruit staff for global expansion
The Standard

Leading Chinese drugmakers with global ambitions such as Jiangsu Hengrui Pharmaceuticals and CanSino Biologics are struggling to recruit internationally experienced staff needed to develop and commercialise promising medicines overseas, industry…

forbes.com - Gary Drenik - CMOs Should Question How AI Agents Make Decisions
CMOs Should Question How AI Agents Make Decisions
Forbes

AI agents can change budgets, shift target audiences, personalize messages, and move to the next decision before anyone on the marketing team sees what happened. By the time, a human review a dashboard, thousands of decisions may already be in…

Receive a Daily briefing on Pharma Industry News

Get Started